Sporadic pancreatic insulinomas (PIs) are challenging lesions with low oncologic risk but a high symptom burden. Despite their low malignant risk, the debilitating symptoms of
rfa
rfa
EUS-RFA Is Highly Effective in the Treatment of Sporadic Pancreatic Insulinomas With Fewer Adverse Events Compared to Surgery
Healing of Mucosal Ablation Areas After Radiofrequency Ablation in Patients With Barrett’s Esophagus
Endoscopic therapy for patients with neoplastic Barrett’s esophagus (BE) involves resection followed by mucosal ablation. Radiofrequency ablation (RFA) of the flat BE mucosa leads to
Endoscopic Submucosal Dissection Plus Radiofrequency Ablation Exhibits High Eradication Rates in Patients With Barrett’s Esophagus
Current strategies for the endoscopic treatment of Barrett’s esophagus (BE) focus on resection of nodular lesions within BE and then the ablation of the flat
Might Biliary Radiofrequency Ablation Be Less Effective Than We Thought?
Most inoperable malignant biliary strictures are best treated with self-expanding metal stents (SEMS); however, a significant portion of patients develop stent occlusion from neoplastic or
Cryoballoon Ablation Has Similar Efficacy to but Higher Stricture Rates Than Radiofrequency Ablation in Barrett’s Endoscopic Therapy
Radiofrequency ablation (RFA) is widely utilized in the treatment of neoplastic Barrett’s esophagus (BE) after endoscopic resection of all visible lesions. Cryotherapy is another form
Radiofrequency Ablation Plus Stent Placement for Extrahepatic Cholangiocarcinoma Shows Benefit Over Stenting Alone
The optimal treatment for cholangiocarcinoma (CCA) or ampullary carcinoma (AC) is surgery. When deemed unresectable and not amenable to neoadjuvant therapy followed by liver transplantation,
Is Barrett’s Esophagus Thickness a Marker for Response to Radiofrequency Ablation Therapy?
Radiofrequency ablation (RFA) is a widely used modality for treating flat Barrett’s esophagus (BE) dysplasia, with the goal of achieving complete eradication of intestinal metaplasia
